August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Global Leaders in Cancer Research Join OncoDaily’s Editorial Board
Aug 15, 2025, 03:01

Global Leaders in Cancer Research Join OncoDaily’s Editorial Board

We are incredibly proud and honored to welcome two world-renowned and visionary leaders in the field of oncology to our esteemed Editorial Board at OncoDaily:

Eric Van Cutsem, MD, Phd

A distinguished Professor of Gastroenterology and Digestive Oncology at the prestigious University of Leuven (KUL) and University Hospitals Gasthuisberg, Dr. Van Cutsem is a globally recognized expert in cancer treatment and research. He serves as a Member of the Belgian Royal Academy of Medicine and is the President of the Belgian Foundation Against Cancer. His groundbreaking work and unwavering dedication have significantly advanced the understanding and treatment of digestive cancers, earning him an outstanding reputation in the international oncology community.

Joyson Karakunnel, MD

As Senior Vice President and Head of Oncology Research at GSK, Dr. Karakunnel brings exceptional expertise, innovative leadership, and a deep commitment to the development of cutting-edge cancer therapies. His visionary approach to oncology research and patient care has led to remarkable strides in transforming the landscape of cancer treatment globally.

With their extraordinary knowledge, trailblazing leadership, and passionate commitment to advancing cancer research and improving patient outcomes, Drs. Van Cutsem and Karakunnel will play a pivotal role in shaping the future direction of OncoDaily. Their invaluable insights will help ensure that we continue to deliver trusted, timely, and impactful oncology news and scientific updates to our diverse and growing global community of researchers, clinicians, and patients alike.

We are excited to embark on this new chapter with such luminaries in cancer research and care, and we look forward to the transformative impact their contributions will bring to OncoDaily and the broader oncology landscape.